According to a popular email (Stockhea*) that I received today;
"Trump’s on the verge of pushing another round of tariffs, this time targeting pharmaceuticals. Experts reckon Aussie pharmaceutical exporters could take a hit of around $1.6 billion a year, with CSL (ASX:CSL) already feeling the sting as its stock price plummeted 4% this morning"
It's understandable for CSL to take a hit based on pharmaceuticals that it exports to the US but LTP will not be exporting to the US. Roxus will be manufactured in the US and not subject to any tariffs. Strange how traders just sell anyway and LTP is down by much more than CSL which actually might be impacted.
LTP Price at posting:
32.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)